Nachrichten zur Nektar Therapeutics Aktie

Nektar (NKTR) Moves 8.5% Higher: Will This Strength Last?

Nektar (NKTR) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might…

Nektar Therapeutics (NKTR) CEO Howard Robin on Q1 2021 Results - Earnings Call Transcript

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Nektar Therapeutics shares rise on narrower Q1 loss

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Nektar Therapeutics (NKTR) Q1 2021 Earnings Call Transcript

NKTR earnings call for the period ending March 31, 2021....…

EARNINGS SUMMARY: Details of Nektar Therapeutics Q1 Earnings Report

WASHINGTON (dpa-AFX) - Below are the earnings highlights for Nektar Therapeutics (NKTR):-Earnings: -$122.97 million in Q1 vs. -$138.65 million in…

Nektar Therapeutics Reports First Quarter 2021 Financial Results

SAN FRANCISCO, May 6, 2021 /PRNewswire/ -- Nektar Therapeutics (Nasdaq: NKTR) today reported financial results for the first quarter ended…

Earnings Preview: Nektar Therapeutics (NKTR) Q1 Earnings Expected to Decline

Nektar (NKTR) doesnt possess the right combination of the two key ingredients for a likely earnings beat in its upcoming…

Nektar to Announce Financial Results for the First Quarter 2021 on Thursday, May 6, 2021, After Close of U.S.-Based Financial Markets

SAN FRANCISCO, April 27, 2021 /PRNewswire/ -- Nektar Therapeutics (Nasdaq: NKTR) will announce its financial results for the first quarter…

Insiderhandel: Aufsichtsrat verkauft Aktien von Nektar Therapeutics im Wert von 151.840$

Chess, Robert - Aufsichtsrat - Tag der Transaktion: 2021-04-14...…

Nektar (NKTR) Down 10.9% Since Last Earnings Report: Can It Rebound?

Nektar (NKTR) reported earnings 30 days ago. Whats next for the stock? We take a look at earnings estimates for…

Nektar Therapeutics Grinding Its Way Toward Pivotal Data

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Nektar Therapeutics Stock Likely To See Higher Levels

Last month we talked about how Nektar Therapeutics stock seems to be a good buying opportunity, and now there have…

Nektar (NKTR) Q4 Earnings and Revenues Top, Pipeline On Track

Nektar (NKTR) reports encouraging fourth-quarter 2020 results. The company plans to initiate a new registrational study on its lead pipeline…

NEKTAR THERAPEUTICS: 10-K Report

10-K...…

Nektar Therapeutics (NKTR) CEO Howard Robin on Q4 2020 Results - Earnings Call Transcript

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Nektar Therapeutics (NKTR) Q4 2020 Earnings Call Transcript

NKTR earnings call for the period ending December 31, 2020....…

EARNINGS SUMMARY: Details of Nektar Therapeutics Q4 Earnings Report

WASHINGTON (dpa-AFX) - Below are the earnings highlights for Nektar Therapeutics (NKTR):-Earnings: -$117.20 million in Q4 vs. -$112.16 million in…

NEKTAR THERAPEUTICS: 8-K Report

CURRENT REPORT...…

Nektar Therapeutics Reports Fourth Quarter and Year-End 2020 Financial Results

SAN FRANCISCO , Feb. 25, 2021 /PRNewswire/ -- Nektar Therapeutics (Nasdaq: NKTR) today reported financial results…

The Zacks Analyst Blog Highlights: Regeneron Pharmaceuticals, Incyte, Nektar Therapeutics, Immunome and Otonomy

The Zacks Analyst Blog Highlights: Regeneron Pharmaceuticals, Incyte, Nektar Therapeutics, Immunome and Otonomy...…

Biotech Stock Roundup: Regulatory Updates From REGN, INCY, & Other Updates

The biotech sector was in focus last week with regulatory and pipeline updates from quite a few companies like Regeneron…

Is a Surprise Coming for Nektar (NKTR) This Earnings Season?

Nektar (NKTR) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season....…

Nektar to Announce Financial Results for the Fourth Quarter and Year-Ended 2020 on Thursday, February 25, 2021, After Close of U.S.-Based Financial Markets

SAN FRANCISCO , Feb. 18, 2021 /PRNewswire/ -- Nektar Therapeutics (Nasdaq: NKTR) will announce its financial…

Nektar (NKTR) Teams Up With Merck for Head & Neck Cancer Study

Nektars (NKTR) shares up following a deal with Merck for a combination study of bempegaldesleukin with Keytruda for advanced head…

Thinking about trading options or stock in Nektar Therapeutics, Sleep Number, General Electric, Twilio, or Spirit Airlines?

NEW YORK , Feb. 18, 2021 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for NKTR,…

NKTR Teams Up With MRK, Pfizer Initiates Multiple Myeloma Trial, PCSA On Watch

KENILWORTH (NJ) (dpa-AFX) - Todays Daily Dose brings you news about Nektars collaboration with Merck; Pfizer initiating a refractory multiple…

NKTR Teams Up With MRK, Pfizer Initiates Multiple Myeloma Trial, PCSA On Watch

Todays Daily Dose brings you news about Nektars collaboration with Merck; Pfizer initiating a refractory multiple myeloma study; Processa Pharmas…

Nektar and Merck team up in mid-stage cancer combo study

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Nektar Therapeutics Secures $150M From SFJ Pharma For New Study With BEMPEG/Pembrolizumab Combo In Head & Neck Cancer

Thinking about trading options or stock in Vir Biotechnology, Verizon, Nektar Therapeutics, Chevron, or Estee Lauder?

NEW YORK , Feb. 17, 2021 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for VIR,…

Nektar Collaborates With SFJ Pharma For Bempegaldesleukin In Head And Neck Cancer

KENILWORTH (NJ) (dpa-AFX) - Nektar Therapeutics (NKTR) said that it has reached a financing and co-development collaboration with SFJ Pharmaceuticals…

NEKTAR THERAPEUTICS: 8-K Report

CURRENT REPORT...…

Thinking about trading options or stock in Nektar Therapeutics, Pfizer, AstraZeneca, Vir Biotechnology, or Esperion Therapeutics?

NEW YORK , Feb. 1, 2021 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for NKTR,…

Nektar Therapeutics (NKTR) Presents At 39th Annual J.P. Morgan Healthcare Conference

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

NEKTAR THERAPEUTICS: 8-K Report

CURRENT REPORT...…

Nektar Therapeutics initiated at hold with $18 price target at Stifel

Um den gesamten Artikel unter marketwatch.com zu lesen, klicken Sie bitte auf die Überschrift...…

NEKTAR THERAPEUTICS: 8-K Report

CURRENT REPORT...…

Nektar Appoints Dr. Brian Kotzin as Interim Chief Medical Officer and Head of Development

SAN FRANCISCO , Jan. 5, 2021 /PRNewswire/ -- Nektar Therapeutics (NASDAQ: NKTR) announced today that…

Implied Volatility Surging for Nektar Therapeutics (NKTR) Stock Options

Investors need to pay close attention to Nektar Therapeutics (NKTR) stock based on the movements in the options market lately....…

Nektar to sell Adynovate, Movantik Royalties for $150M

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

NEKTAR THERAPEUTICS: 8-K Report

CURRENT REPORT...…

Nektar Therapeutics Announces Agreement with Healthcare Royalty to Sell ADYNOVATE® and MOVANTIK® Royalties for $150 Million

SAN FRANCISCO , Dec. 22, 2020 /PRNewswire/ -- Nektar Therapeutics (NASDAQ: NKTR) today announced that it…

Nektar (NKTR) Begins Dosing in NKTR-255 Study for Two Cancers

Nektar (NKTR) doses the first patient in a phase I/II study on NKTR-255 in combination with Erbitux for treating head…

Nektar Therapeutics Announces Presentation of Preclinical Data for NKTR-255, its Novel IL-15 Agonist, at the American Society of Hematology (ASH) 2020 Annual Meeting

SAN FRANCISCO , Dec. 7, 2020 /PRNewswire/ -- Nektar Therapeutics (NASDAQ: NKTR) today announced…

Nektar Therapeutics: A Look At The SITC BEMPEG Data

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Nektar Therapeutics immuno-oncology candidates show positive action in early-stage studies

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Nektar Therapeutics Presents New Data from Its Immuno-Oncology Pipeline at the 2020 Society for Immunotherapy of Cancer (SITC) Annual Meeting

SAN FRANCISCO , Nov. 11, 2020 /PRNewswire/ -- Nektar Therapeutics (Nasdaq: NKTR) today announced…